Vinge has advised Oncopeptides AB (publ). Oncopeptides AB (publ) has announced a partially guaranteed rights issue expected to raise approximately SEK 200 million in gross proceeds...
Oncopeptides Announces SEK 200 Million Rights Issue
Oncopeptides Executes Fully Guaranteed SEK 150 Million Rights Issue
Vinge has advised Oncopeptides AB (publ). Oncopeptides AB (publ) has completed a fully guaranteed rights issue expected to generate proceeds of approximately SEK 150 million before...
Hansa Biopharma Completes SEK 232 Million Directed Share Issue and Debt Restructuring
Vinge has advised Hansa Biopharma AB (publ). Hansa Biopharma AB (publ) has executed a directed share issue, securing approximately SEK 232 million in gross proceeds, alongside...